S&P Pharma Dose podcast

What Bausch RemainCo's Credit Quality Post-Spinoff Could Look Like

0:00
7:06
Spol 15 sekunder tilbage
Spol 15 sekunder frem
In this episode, Ji Liu, primary analyst for Bausch Health, discusses a number of investor questions after Bausch announced its intention to spin off its eye health business unit, specifically regarding its capital structure, key business strengths, key business weaknesses, and other concerns.

Flere episoder fra "S&P Pharma Dose"